Showing 500 results

Filters Content type: News, Editors' picks Topic: Resistance

Poor adherence and the subsequent development of drug resistance is one reason why HIV treatment can fail. A drug-resistant HIV strain is one which is less susceptible to the effects of one or more anti-HIV drugs.

Sexually transmitted infections prevention

DoxyPEP Use Linked to Increased High-Level Tetracycline Resistance in Neisseria gonorrhoeae

Editor's pick
Contagion Live
26 November 2025
Resistance

New WHO framework aims to tackle rising resistance to HIV, STI, and hepatitis treatments

Editor's pick
CIDRAP
26 November 2025
Resistance

New Data Support Lenacapavir for Treatment-Experienced HIV

Editor's pick
Medscape (requires free registration)
26 November 2025
New & experimental HIV treatments

Lenacapavir drug resistance in phase 1b study

Editor's pick
i-Base
25 November 2025
New & experimental HIV treatments

Gilead hails phase 3 victory for single-tablet combo of bictegravir and lenacapavir, preps filings

Editor's pick
FiercePharma
17 November 2025
Resistance

Resistance following failure of injectable cabotegravir/rilpivirine may limit future treatment options

News
22 October 2025
Resistance

HIV Drug Resistance Is Declining Over Time

Editor's pick
POZ
25 September 2025
Treatment simplification strategies

Intermittent HIV treatment dosing may be a response to the funding crisis, but adolescent study raises concerns

News
17 July 2025
Resistance

High rates of HIV drug resistance among young people in London will limit future treatment options

News
8 May 2025
Injectable & long-acting HIV treatment

Potential for bictegravir and dolutegravir to overcome resistance to CAB/RPV-LA

Editor's pick
i-Base
14 April 2025
Sexually transmitted infections epidemiology

CDC’s top laboratory on sexually transmitted diseases is shut by Trump administration

Editor's pick
STAT
7 April 2025
Changing treatment

Dolutegravir resistance very rare after a switch - even with detectable HIV

News
8 July 2024
Resistance

Lamivudine resistance mutation may persist for many years in some people with HIV

News
4 July 2024
Injectable & long-acting HIV treatment

Injectable HIV treatment underway in England and largely effective, but a couple of breakthrough cases raise concern

News
8 May 2024
Injectable & long-acting HIV treatment

Caution advised when prescribing long-acting injectable cabotegravir and rilpivirine to avoid drug resistance

News
30 April 2024
Sexually transmitted infections prevention

Dissent on doxyPEP: recent guidelines becoming more cautious

News
26 April 2024
Resistance

Widely used HIV drug in South Africa flagged for reports of resistance – but experts say don’t panic

Editor's pick
Spotlight
16 April 2024
HIV treatment

Top 5 HIV treatment stories from CROI 2024

News
18 March 2024
Resistance

The cornerstone of HIV treatment may be losing some of its power: will dolutegravir resistance become a problem?

News
12 March 2024
Resistance

New report documents increase in HIV drug resistance to dolutegravir

Editor's pick
World Health Organization
6 March 2024
Resistance

FDA Expands Indication for Biktarvy to for Resistant HIV

Editor's pick
Infectious Disease Special Edition
1 March 2024
Resistance

U.S. FDA Approves Expanded Indication for Gilead’s Biktarvy® to Treat People with HIV with Suppressed Viral Loads, Pre-existing Resistance

Editor's pick
Gilead Sciences press release
27 February 2024
How HIV works

Higher viral load during HIV infection can shape viral evolution

Editor's pick
EurekAlert!
10 January 2024
PrEP science

Resistance Mutation Associated With PrEP Use in People Newly Diagnosed With HIV in New York City

Editor's pick
TheBodyPro
5 January 2024